166 related articles for article (PubMed ID: 31194837)
21. Aberrant methylation status of SPG20 promoter in hepatocellular carcinoma: A potential tumor metastasis biomarker.
He L; Fan X; Li Y; Cui B; Shi Z; Zhou D; Lin H
Cancer Genet; 2019 Apr; 233-234():48-55. PubMed ID: 31109594
[TBL] [Abstract][Full Text] [Related]
22. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
[TBL] [Abstract][Full Text] [Related]
23. Implication of Reprimo and hMLH1 gene methylation in early diagnosis of gastric carcinoma.
Liu L; Yang X
Int J Clin Exp Pathol; 2015; 8(11):14977-82. PubMed ID: 26823831
[TBL] [Abstract][Full Text] [Related]
24. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
25. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation profiling identifies epigenetic signatures of early gastric cancer.
Shi Z; Guo X; Hu X; Li R; Li X; Lu J; Jin M; Jiang X
Virchows Arch; 2024 Apr; 484(4):687-695. PubMed ID: 38507065
[TBL] [Abstract][Full Text] [Related]
27. KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells.
Frazzi R; Cusenza VY; Pistoni M; Canovi L; Cascione L; Bertoni F; Merli F
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34751409
[TBL] [Abstract][Full Text] [Related]
28. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
29. SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis.
Lind GE; Raiborg C; Danielsen SA; Rognum TO; Thiis-Evensen E; Hoff G; Nesbakken A; Stenmark H; Lothe RA
Oncogene; 2011 Sep; 30(37):3967-78. PubMed ID: 21499309
[TBL] [Abstract][Full Text] [Related]
30. CD40 DNA hypermethylation in primary gastric tumors; as a novel diagnostic biomarker.
Amini M; Ghorban K; Mokhtarzadeh A; Dadmanesh M; Baradaran B
Life Sci; 2020 Aug; 254():117774. PubMed ID: 32407843
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer.
Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H
Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515
[TBL] [Abstract][Full Text] [Related]
32. DKK1 is epigenetically downregulated by promoter methylation and inhibits bile acid-induced gastric intestinal metaplasia.
Lu W; Ni Z; Tong M; Jiang S; Zhang J; Feng C; Han C; Yuan T; Wang N; Zhao J; Sun N; Liu C; Jia Q; Wu Q; Ning H; Shi Y
Biochem Biophys Res Commun; 2020 Mar; 523(3):780-786. PubMed ID: 31952791
[TBL] [Abstract][Full Text] [Related]
33. Role of PCDH10 and its hypermethylation in human gastric cancer.
Li Z; Chim JC; Yang M; Ye J; Wong BC; Qiao L
Biochim Biophys Acta; 2012 Feb; 1823(2):298-305. PubMed ID: 22206871
[TBL] [Abstract][Full Text] [Related]
34. DNA damage-inducible gene, reprimo functions as a tumor suppressor and is suppressed by promoter methylation in gastric cancer.
Ooki A; Yamashita K; Yamaguchi K; Mondal A; Nishimiya H; Watanabe M
Mol Cancer Res; 2013 Nov; 11(11):1362-74. PubMed ID: 23982217
[TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis and diagnostic significance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patients.
Ng EK; Leung CP; Shin VY; Wong CL; Ma ES; Jin HC; Chu KM; Kwong A
PLoS One; 2011; 6(7):e22233. PubMed ID: 21789241
[TBL] [Abstract][Full Text] [Related]
36. Promoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancer.
Liu X; Lam EK; Wang X; Zhang J; Cheng YY; Lam YW; Ng EK; Yu J; Chan FK; Jin H; Sung JJ
Tumour Biol; 2009; 30(5-6):242-8. PubMed ID: 19816091
[TBL] [Abstract][Full Text] [Related]
37. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
[TBL] [Abstract][Full Text] [Related]
38. Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer.
Cheng YY; Jin H; Liu X; Siu JM; Wong YP; Ng EK; Yu J; Leung WK; Sung JJ; Chan FK
Br J Cancer; 2008 Dec; 99(12):2083-7. PubMed ID: 18985039
[TBL] [Abstract][Full Text] [Related]
39. Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer.
Zhang XM; Zhou C; Gu H; Yan L; Zhang GY
Int J Clin Exp Pathol; 2014; 7(9):5902-8. PubMed ID: 25337233
[TBL] [Abstract][Full Text] [Related]
40. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
